LONG-TERM EFFICACY AND SAFETY OF DEPRENYL (SELEGILINE) IN ADVANCED PARKINSONS-DISEASE

被引:48
作者
GOLBE, LI
机构
关键词
D O I
10.1212/WNL.39.8.1109
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:1109 / 1111
页数:3
相关论文
共 7 条
[1]   HYPERTENSIVE INTERACTIONS BETWEEN MONOAMINE OXIDASE INHIBITORS AND FOODSTUFFS [J].
BLACKWELL, B ;
MARLEY, E ;
PRICE, J ;
TAYLOR, D .
BRITISH JOURNAL OF PSYCHIATRY, 1967, 113 (497) :349-+
[2]   DEPRENYL AS SYMPTOMATIC THERAPY IN PARKINSONS-DISEASE [J].
GOLBE, LI .
CLINICAL NEUROPHARMACOLOGY, 1988, 11 (05) :387-400
[3]   DEPRENYL IN THE TREATMENT OF SYMPTOM FLUCTUATIONS IN ADVANCED PARKINSONS-DISEASE [J].
GOLBE, LI ;
LIEBERMAN, AN ;
MUENTER, MD ;
AHLSKOG, JE ;
GOPINATHAN, G ;
NEOPHYTIDES, AN ;
FOO, SH ;
DUVOISIN, RC .
CLINICAL NEUROPHARMACOLOGY, 1988, 11 (01) :45-55
[4]  
LEES AJ, 1988, DEPRENYL PARKINSONS, P20
[5]  
SHOULSON I, IN PRESS HDB EXPT PH
[6]   DEPRENYL AS PROPHYLAXIS AGAINST PARKINSONS-DISEASE [J].
SONSALLA, PK ;
GOLBE, LI .
CLINICAL NEUROPHARMACOLOGY, 1988, 11 (06) :500-511
[7]  
1985, IMPROVING LIFE PARKI